Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Public Health ; 114(S2): 156-161, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38354340

RESUMO

Health care workers (n = 71) completed an online survey or participated in one of five focus groups. Clinical cutoff scores revealed concerning levels of depression (16%), anxiety, and burnout (49%). Qualitative responses (n = 172) yielded two themes: work environment and well-being. Addressing burnout requires an ecological systems mindset, which accounts for complex stressors present in individual providers' lives (large-scale disasters and personal stressors), agency-level factors (scheduling and workload), and larger social and contextual administrative factors (allocating time for self-care through scheduling and billing codes). (Am J Public Health. 2024;114(S2):S156-S161. https://doi.org/10.2105/AJPH.2023.307478).


Assuntos
Esgotamento Profissional , Saúde Mental , Humanos , Área Carente de Assistência Médica , Esgotamento Profissional/epidemiologia , Esgotamento Profissional/psicologia , Pessoal de Saúde/psicologia , Condições de Trabalho , Recursos Humanos
2.
Sci Rep ; 12(1): 961, 2022 01 19.
Artigo em Inglês | MEDLINE | ID: mdl-35046499

RESUMO

In addition to concern about physical health consequences of COVID-19, many researchers also note the concerning impact on behavioral health and quality of life due to disruption. The purpose of this paper is to explore pathways of COVID-19 behavioral health and quality of life. We found increased anxiety, depression, and alcohol misuse and that the pandemic exacerbated prior problems. Further community indicators also lead to poorer behavioral health and overall decreased quality of life. The nature of COVID-19 and vast reach of the virus suggests that behavioral health concerns should take a primary role in pandemic recovery.


Assuntos
Ansiedade/epidemiologia , COVID-19/psicologia , Depressão/epidemiologia , Saúde Mental/estatística & dados numéricos , Qualidade de Vida , SARS-CoV-2/isolamento & purificação , Estresse Psicológico/epidemiologia , Adolescente , Adulto , Idoso , Ansiedade/psicologia , COVID-19/epidemiologia , COVID-19/virologia , Estudos Transversais , Depressão/psicologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Psiquiatria , Estresse Psicológico/psicologia , Estados Unidos/epidemiologia , Adulto Jovem
3.
J Racial Ethn Health Disparities ; 9(5): 1662-1669, 2022 10.
Artigo em Inglês | MEDLINE | ID: mdl-34254269

RESUMO

This study aimed to assess time to hepatitis C (HCV) treatment (i.e., the time between the initial clinic visit for HCV evaluation and the HCV treatment start date), to compare clinical characteristics between patients who received HCV treatment ≥ and < 6 months, and to identify predictors of longer time to HCV treatment in patients living with HCV. This study conducted a retrospective secondary analysis of patients living with HCV mono-infection and HIV/HCV co-infection who received HCV treatment with DAAs (n=214) at a HIV Clinic. Binomial logistic regression was used to identify predictors of longer time to treatment (i.e., ≥ 6 months). The median time to HCV treatment was 211 days. Compared to patients who were treated < 6 months, a higher proportion of patients who were treated ≥ 6 months had HIV/HCV co-infection (31% vs. 49%, p=0.01) and chronic kidney disease (8% vs. 18%, p=0.03). In multivariate analysis, HIV/HCV co-infection was positively associated with a longer time to HCV treatment (adjusted odds ratio, aOR=2.0, p=0.03). Time to HCV treatment disparities between African American and White American did not emerge from the analysis, but time to HCV treatment disfavored patients living with HIV/HCV co-infection. Studies are needed to identify and eliminate factors that disfavor patients living with HIV/HCV co-infection.


Assuntos
Coinfecção , Infecções por HIV , Hepatite C , Infecções por HIV/tratamento farmacológico , Hepatite C/tratamento farmacológico , Humanos , Razão de Chances , Estudos Retrospectivos
4.
Soc Work Public Health ; 36(3): 344-353, 2021 04 03.
Artigo em Inglês | MEDLINE | ID: mdl-33685384

RESUMO

Although obesity and depression are quite common among older adults, surprisingly published literature has not examined factors associated with co-occurring depression and obesity among older adults. The knowledge that fills this gap would be advantageous for public health social workers and other health professionals who provide health care and public health services to older adults. The objectives of this study were to access the prevalence of and independent predictors of co-occurring depression and obesity among older adults in the state of Alabama. A retrospective analysis was conducted using a statewide survey of Alabamian community-dwelling older adults (n = 1,166). Binomial logistic regression was used to examine predictors of co-occurring depression and obesity. The prevalence of co-occurring depression and obesity among older adults was 16%. In the multivariate analysis, African American ethnicity (OR = 1.505, CI: 1.019-2.223), hypertension (OR = 1.593, CI: 1.050-2.416), diabetes (OR = 1.768, CI: 1.188-2.632), and arthritis (OR = 1.640, CI: 1.096-2.454) were positively associated with co-occurring depression and obesity). Older age (OR = 0.963, CI: 0.942-0.985) and higher levels of physical activity (OR = 1.640, CI: 1.096-2.454) were negatively associated with co-occurring depression and obesity. There is a need for the development and implementation of suitable interventions to prevent and manage co-occurring depression and obesity among older adults, particularly older adults with arthritis, hypertension, diabetes, or of African American ethnicity.


Assuntos
Artrite , Diabetes Mellitus , Hipertensão , Negro ou Afro-Americano , Idoso , Estudos Transversais , Depressão/epidemiologia , Diabetes Mellitus/epidemiologia , Etnicidade , Humanos , Hipertensão/epidemiologia , Vida Independente , Obesidade/epidemiologia , Prevalência , Estudos Retrospectivos
5.
Soc Work Health Care ; 59(7): 525-541, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32873213

RESUMO

The objectives of this study were to estimate the prevalence of concurrent alcohol and substance use among patients living with HIV/HCV co-infection and to compare demographic and clinical characteristics of those with concurrent alcohol and substance to those with alcohol or substance use, and to those who were abstinent. We conducted an analysis of patient reported outcomes data of patients living with HIV/HCV co-infection (n = 327) who transitioned from primary care to sub-specialty care for evaluation of candidacy for HCV treatment at a university-affiliated HIV Clinic. The prevalence of self-reported concurrent alcohol and substance use was 33%. A higher proportion of those with concurrent alcohol and substance use were currently smoking tobacco, and those who were abstinent had higher ratings of health-related quality of life compared to those with alcohol or substance use. To reduce patients' risk for progression to advanced stages of HIV, HCV, and liver-related disease due to continued alcohol and substance and tobacco use, social workers and other health care professionals are encouraged to develop and implement intervention strategies to assist patients living with HIV/HCV co-infection in efforts to achieve behavioral change.


Assuntos
Infecções por HIV/epidemiologia , Hepatite C/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Adulto , Idoso , Alcoolismo/epidemiologia , Feminino , Humanos , Hepatopatias/epidemiologia , Masculino , Saúde Mental , Pessoa de Meia-Idade , Qualidade de Vida , Estudos Retrospectivos , Fatores de Risco , Fatores Socioeconômicos , Abuso de Substâncias por Via Intravenosa/epidemiologia , Fumar Tabaco/epidemiologia , Estados Unidos/epidemiologia
6.
Geriatr Gerontol Int ; 18(9): 1356-1360, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30094913

RESUMO

AIM: The objectives of the present study were to estimate the prevalence of co-occurring diabetes and hypertension among older adults, examine predictors of co-occurring diabetes and hypertension, and ascertain whether predictors varied by race. METHODS: A retrospective analysis was carried out using a statewide survey of Alabama community-dwelling older adults (n = 1204). Measures of central tendency and frequency distributions were used for univariate analysis. Logistic regression was used to predict co-occurring diabetes and hypertension. RESULTS: The prevalence of co-occurring diabetes and hypertension among older adults was 17%. African American race (OR 2.28, 95% CI 1.596-3.255), body mass index ≥30 (OR 2.45, 95% CI 1.732-3.463), heart disease (OR 1.93, 95% CI 1.355-2.756) and eye disease (OR 1.44, 95% CI 1.018-2.024) were associated positively with co-occurring diabetes and hypertension. CONCLUSIONS: The prevalence of co-occurring diabetes and hypertension among older adults was alarmingly high. The notable difference in the likelihood of co-occurring diabetes and hypertension is representative of a racial health disparity that largely disfavors African American older adults. Findings from the present study highlight a need for identification of older adults who have and who are at risk of co-occurring diabetes and hypertension in the general population and in clinical settings, and the development and implementation of suitable interventions, particularly targeting older African American adults. Geriatr Gerontol Int 2018; 18: 1356-1360.


Assuntos
Negro ou Afro-Americano/estatística & dados numéricos , Diabetes Mellitus/diagnóstico , Diabetes Mellitus/epidemiologia , Hipertensão/diagnóstico , Hipertensão/epidemiologia , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Alabama , Análise de Variância , Índice de Massa Corporal , Estudos de Coortes , Comorbidade , Intervalos de Confiança , Bases de Dados Factuais , Diabetes Mellitus/tratamento farmacológico , Feminino , Avaliação Geriátrica/métodos , Humanos , Hipertensão/tratamento farmacológico , Vida Independente , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Obesidade/epidemiologia , Razão de Chances , Valor Preditivo dos Testes , Prevalência , Prognóstico , Estudos Retrospectivos , Medição de Risco , Índice de Gravidade de Doença , Distribuição por Sexo
7.
J Community Health ; 43(4): 725-730, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-29511988

RESUMO

This study describes clinical characteristics of poor and uninsured patients living with hepatitis C virus (HCV) who received care from a multidisciplinary HCV clinic, reports treatment completion and cure rates, and estimates the cost of HCV medications provided at no cost to uninsured patients. A retrospective chart review was performed and identified 69 uninsured HCV patients who received medical care at Mercy Health Center, a small non-profit community clinic, between January 2008 and March 2015. Three-fourths of the patients were unemployed, a third had multiple HCV exposures, nearly half acquired HCV due to illicit drug use, and more than half had active psychiatric disorders. Of those who received HCV treatment, 81% completed treatment and 85% were achieved virological cure. The multidisciplinary community clinic provided > $1.4 million of HCV antivirals at no cost to uninsured patients. Findings suggest a multidisciplinary community clinic comprised of a social worker, pharmacist, gastroenterologist, nurse, nurse practitioner, psychologist, and dietitian can help patients achieve HCV treatment completion and cure rates comparable to traditional physician-led clinics, and successfully manage uninsured and underserved HCV patients-who are often regarded as "difficult-to-treat" patients. Public health social workers and other health professionals are encouraged to advocate for treatment and care of poor and uninsured patients living with HCV in health agencies and health systems, otherwise population-wide reductions in HCV morbidity and mortality will not be realized.


Assuntos
Instituições de Assistência Ambulatorial/organização & administração , Serviços de Saúde Comunitária/organização & administração , Hepatite C/terapia , Pessoas sem Cobertura de Seguro de Saúde , Adulto , Antivirais/uso terapêutico , Feminino , Hepatite C/tratamento farmacológico , Humanos , Masculino , Transtornos Mentais/epidemiologia , Pessoa de Meia-Idade , Organizações sem Fins Lucrativos , Equipe de Assistência ao Paciente/organização & administração , Estudos Retrospectivos , Abuso de Substâncias por Via Intravenosa/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...